Researchers
-
Anna Planas Ballvé
Clinical neuropsychiatry and neuropsychology
-
Asunción Ávila
Clinical neuropsychiatry and neuropsychology
Phd -
Dolores Lozano
Clinical neuropsychiatry and neuropsychology
-
Ester Moral Torres
Clinical neuropsychiatry and neuropsychology
-
Irati Zubizarreta
Clinical neuropsychiatry and neuropsychology
Phd -
Joan Bello López
Clinical neuropsychiatry and neuropsychology
Phd -
José Vicente Hervas-garcía
Clinical neuropsychiatry and neuropsychology
Phd -
Juan Bernardo Gómez
Clinical neuropsychiatry and neuropsychology
-
Juan José Mengual
Clinical neuropsychiatry and neuropsychology
-
Laura Gubieras Lillo
Clinical neuropsychiatry and neuropsychology
-
Mª Isabel Gómez Ruiz
Clinical neuropsychiatry and neuropsychology
Phd -
Marta Balagué
Clinical neuropsychiatry and neuropsychology
-
Mercè Leixà
Clinical neuropsychiatry and neuropsychology
-
Mireia Grau
Clinical neuropsychiatry and neuropsychology
-
Monica Prat
Clinical neuropsychiatry and neuropsychology
-
Montse Vacas Moreira
Clinical neuropsychiatry and neuropsychology
-
Nuria Caballol
Clinical neuropsychiatry and neuropsychology
-
Pablo Millet Balance
Clinical neuropsychiatry and neuropsychology
-
Sonia Maria Garcia
Clinical neuropsychiatry and neuropsychology
-
Xavier Cardona
Clinical neuropsychiatry and neuropsychology
Contact the group
Form
Projects
-
- Year 2019
- L'Hospitalet General Hospital
Observational, prospective, multinational, multicenter study comparing the effectiveness of Safinamide, Rasagiline and other standard treatments as complementary treatment to Levadopa (L-dopa) in patients with fluctuating Parkinson's disease (PD).
-
DISTRICT ATTORNEY:
Zambon S.p.A
-
TYPE E:
EPA-SP
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2018
- Hospital General de l'Hospitalet
Language and non-verbal cognition in adults with aphasia
-
DISTRICT ATTORNEY:
Dr. Wolfram Hinzen
-
TYPE E:
PI
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2018
- Dos de Maig Comprehensive Care Center
Observational study to determine the safety profile of Opicapona in patients with Parkinson's disease under conditions of usual clinical practice,
-
DISTRICT ATTORNEY:
Laboratorios Bial SA
-
TYPE E:
EPA
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Prospective study, lasting two years, to evaluate the health-related quality of life in subjects with highly active relapsing multiple sclerosis treated with Mavenclad®,
-
DISTRICT ATTORNEY:
Merck KGaA
-
TYPE E:
RD2015
-
- Year 2018
- Dos de Maig Comprehensive Care Center
Observational study to determine the safety profile of Opicapona in patients with Parkinson's disease under conditions of usual clinical practice,
-
DISTRICT ATTORNEY:
Laboratorios Bial SA
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Prospective study, lasting two years, to evaluate the health-related quality of life in subjects with highly active relapsing multiple sclerosis treated with Mavenclad®,
-
DISTRICT ATTORNEY:
Merck KGaA
-
TYPE E:
RD2015
-
- Year 2018
- L'Hospitalet General Hospital
Language and non-verbal cognition in adults with aphasia
-
DISTRICT ATTORNEY:
Dr. Wolfram Hinzen
-
TYPE E:
PINE TREE
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Preferences of patients and neurologists for the characteristics of second-line treatments for multiple sclerosis in Spain,
-
DISTRICT ATTORNEY:
Merck SL,
-
TYPE E:
EPA
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Psychological Intervention of Agoraphobia through Virtual Reality (Agora VR),
-
DISTRICT ATTORNEY:
TicSalut and Psious
-
TYPE E:
PI
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Multicentric project on the bio-psycho-social profile of women diagnosed with fibromyalgia,
-
DISTRICT ATTORNEY:
University of Barcelona
-
TYPE E:
PI
- Parkinson's disease in our area
- Psychiatric pathology in neurological diseases
- Bilingualism in dementia, stroke and movement disorders
- Multiple Sclerosis: treatment and quality of life
- Cognitive and fluid biomarkers in neurodegenerative disorders
